BLASTP 2.2.26 [Sep-21-2011]
Reference: Altschul, Stephen F., Thomas L. Madden, Alejandro A. Schaffer,
Jinghui Zhang, Zheng Zhang, Webb Miller, and David J. Lipman (1997),
"Gapped BLAST and PSI-BLAST: a new generation of protein database search
programs", Nucleic Acids Res. 25:3389-3402.
Reference for compositional score matrix adjustment: Altschul, Stephen F.,
John C. Wootton, E. Michael Gertz, Richa Agarwala, Aleksandr Morgulis,
Alejandro A. Schaffer, and Yi-Kuo Yu (2005) "Protein database searches
using compositionally adjusted substitution matrices", FEBS J. 272:5101-5109.
Query= 016163
(394 letters)
Database: pdbaa
62,578 sequences; 14,973,337 total letters
Searching..................................................done
>pdb|3G33|B Chain B, Crystal Structure Of Cdk4CYCLIN D3
pdb|3G33|D Chain D, Crystal Structure Of Cdk4CYCLIN D3
Length = 306
Score = 71.2 bits (173), Expect = 1e-12, Method: Compositional matrix adjust.
Identities = 61/222 (27%), Positives = 97/222 (43%), Gaps = 14/222 (6%)
Query: 114 WMLKVNAHYSFTALTALLAVNYLDRFLFSFQLQRDKPWMAQLAAVACLSLAAKVEETQVP 173
WML+V LA+NYLDR+L ++ + QL C+ LA+K+ ET P
Sbjct: 77 WMLEVCEEQRCEEEVFPLAMNYLDRYLSCVPTRKAQ---LQLLGAVCMLLASKLRET-TP 132
Query: 174 LLLDLQVEDIKFVFEAKTIQRMEILVLSTLQWKMNPVTPLSFLDYIARRLGLKGYLCWEF 233
L ++ + ++ E+LVL L+W + V FL +I RL L
Sbjct: 133 LTIEKLCIYTDHAVSPRQLRDWEVLVLGKLKWDLAAVIAHDFLAFILHRLSLPRDRQALV 192
Query: 234 LKRCDRILLSAISDSSFMQYLPSVMANATMLHVVQNIE--SSLGVEYEKQLLNILGTDKD 291
K L +D +F Y PS++A ++ VQ + S G E + L I GT+ D
Sbjct: 193 KKHAQTFLALCATDYTFAMYPPSMIATGSIGAAVQGLGACSMSGDELTELLAGITGTEVD 252
Query: 292 KVEHCSKLIMQLAEQVQGQGSQSIKRKFGSITVPVVPGSPNG 333
+ C EQ++ +S++ + + P P +P G
Sbjct: 253 CLRACQ-------EQIEAALRESLREAAQTSSSP-APKAPRG 286
>pdb|1VYW|B Chain B, Structure Of Cdk2CYCLIN A WITH PNU-292137
pdb|1VYW|D Chain D, Structure Of Cdk2CYCLIN A WITH PNU-292137
pdb|2C4G|B Chain B, Structure Of Cdk2-Cyclin A With Pha-533514
pdb|2C4G|D Chain D, Structure Of Cdk2-Cyclin A With Pha-533514
pdb|2BPM|B Chain B, Structure Of Cdk2-Cyclin A With Pha-630529
pdb|2BPM|D Chain D, Structure Of Cdk2-Cyclin A With Pha-630529
pdb|2BKZ|B Chain B, Structure Of Cdk2-Cyclin A With Pha-404611
pdb|2BKZ|D Chain D, Structure Of Cdk2-Cyclin A With Pha-404611
pdb|2WIH|B Chain B, Structure Of Cdk2-Cyclin A With Pha-848125
pdb|2WIH|D Chain D, Structure Of Cdk2-Cyclin A With Pha-848125
pdb|2WIP|B Chain B, Structure Of Cdk2-Cyclin A Complexed With 8-Anilino-1-
Methyl-4,5-Dihydro-1h-Pyrazolo[4,3-H] Quinazoline-3-
Carboxylic Acid
pdb|2WIP|D Chain D, Structure Of Cdk2-Cyclin A Complexed With 8-Anilino-1-
Methyl-4,5-Dihydro-1h-Pyrazolo[4,3-H] Quinazoline-3-
Carboxylic Acid
pdb|2WPA|B Chain B, Optimisation Of 6,6-Dimethyl Pyrrolo 3,4-C Pyrazoles:
Identification Of Pha-793887, A Potent Cdk Inhibitor
Suitable For Intravenous Dosing
pdb|2WPA|D Chain D, Optimisation Of 6,6-Dimethyl Pyrrolo 3,4-C Pyrazoles:
Identification Of Pha-793887, A Potent Cdk Inhibitor
Suitable For Intravenous Dosing
pdb|2WXV|B Chain B, Structure Of Cdk2-Cyclin A With A Pyrazolo(4,3-H)
Quinazoline-3-Carboxamide Inhibitor
pdb|2WXV|D Chain D, Structure Of Cdk2-Cyclin A With A Pyrazolo(4,3-H)
Quinazoline-3-Carboxamide Inhibitor
Length = 265
Score = 66.6 bits (161), Expect = 2e-11, Method: Compositional matrix adjust.
Identities = 66/230 (28%), Positives = 104/230 (45%), Gaps = 24/230 (10%)
Query: 98 LKTNPSLSRA-RSEAVDWMLKVNAHYSFTALTALLAVNYLDRFLFSFQLQRDKPWMAQLA 156
+K P ++ + R+ VDW+++V Y T LAVNY+DRFL S + R K QL
Sbjct: 33 MKKQPDITNSMRAILVDWLVEVGEEYKLQNETLHLAVNYIDRFLSSMSVLRGK---LQLV 89
Query: 157 AVACLSLAAKVEETQVPLLLDLQVEDIKFV----FEAKTIQRMEILVLSTLQWKMNPVTP 212
A + LA+K EE P +V + ++ + K + RME LVL L + + T
Sbjct: 90 GTAAMLLASKFEEIYPP-----EVAEFVYITDDTYTKKQVLRMEHLVLKVLTFDLAAPTV 144
Query: 213 LSFL-DYIARR--LGLKGYLCWEFLKRCDRILLSAISDSSFMQYLPSVMANATMLHVVQN 269
FL Y + K FL LS I +++YLPSV+A A H+
Sbjct: 145 NQFLTQYFLHQQPANCKVESLAMFLGE-----LSLIDADPYLKYLPSVIAGAA-FHLA-- 196
Query: 270 IESSLGVEYEKQLLNILGTDKDKVEHCSKLIMQLAEQVQGQGSQSIKRKF 319
+ + G + + L+ G + ++ C + Q + QSI+ K+
Sbjct: 197 LYTVTGQSWPESLIRKTGYTLESLKPCLMDLHQTYLKAPQHAQQSIREKY 246
>pdb|1QMZ|B Chain B, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex
pdb|1QMZ|D Chain D, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex
pdb|1H24|B Chain B, Cdk2CYCLIN A IN COMPLEX WITH A 9 RESIDUE RECRUITMENT
Peptide From E2f
pdb|1H24|D Chain D, Cdk2CYCLIN A IN COMPLEX WITH A 9 RESIDUE RECRUITMENT
Peptide From E2f
pdb|1H25|B Chain B, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
Peptide From Retinoblastoma-Associated Protein
pdb|1H25|D Chain D, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
Peptide From Retinoblastoma-Associated Protein
pdb|1H26|B Chain B, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
Peptide From P53
pdb|1H26|D Chain D, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
Peptide From P53
pdb|1H27|B Chain B, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
Peptide From P27
pdb|1H27|D Chain D, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
Peptide From P27
pdb|1H28|B Chain B, Cdk2/cyclin A In Complex With An 11-residue Recruitment
Peptide From P107
pdb|1H28|D Chain D, Cdk2/cyclin A In Complex With An 11-residue Recruitment
Peptide From P107
pdb|2C5N|B Chain B, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5N|D Chain D, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5V|B Chain B, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5V|D Chain D, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5X|B Chain B, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5X|D Chain D, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2UUE|B Chain B, Replace: A Strategy For Iterative Design Of Cyclin Binding
Groove Inhibitors
pdb|2UUE|D Chain D, Replace: A Strategy For Iterative Design Of Cyclin Binding
Groove Inhibitors
pdb|2V22|B Chain B, Replace: A Strategy For Iterative Design Of Cyclin Binding
Groove Inhibitors
pdb|2V22|D Chain D, Replace: A Strategy For Iterative Design Of Cyclin Binding
Groove Inhibitors
pdb|2WMA|B Chain B, Structural And Thermodynamic Consequences Of Cyclization
Of Peptide Ligands For The Recruitment Site Of Cyclin A
pdb|2WMA|D Chain D, Structural And Thermodynamic Consequences Of Cyclization
Of Peptide Ligands For The Recruitment Site Of Cyclin A
pdb|2WMB|B Chain B, Structural And Thermodynamic Consequences Of Cyclization
Of Peptide Ligands For The Recruitment Site Of Cyclin A
pdb|2WMB|D Chain D, Structural And Thermodynamic Consequences Of Cyclization
Of Peptide Ligands For The Recruitment Site Of Cyclin A
Length = 259
Score = 66.6 bits (161), Expect = 2e-11, Method: Compositional matrix adjust.
Identities = 66/230 (28%), Positives = 104/230 (45%), Gaps = 24/230 (10%)
Query: 98 LKTNPSLSRA-RSEAVDWMLKVNAHYSFTALTALLAVNYLDRFLFSFQLQRDKPWMAQLA 156
+K P ++ + R+ VDW+++V Y T LAVNY+DRFL S + R K QL
Sbjct: 27 MKKQPDITNSMRAILVDWLVEVGEEYKLQNETLHLAVNYIDRFLSSMSVLRGK---LQLV 83
Query: 157 AVACLSLAAKVEETQVPLLLDLQVEDIKFV----FEAKTIQRMEILVLSTLQWKMNPVTP 212
A + LA+K EE P +V + ++ + K + RME LVL L + + T
Sbjct: 84 GTAAMLLASKFEEIYPP-----EVAEFVYITDDTYTKKQVLRMEHLVLKVLTFDLAAPTV 138
Query: 213 LSFL-DYIARR--LGLKGYLCWEFLKRCDRILLSAISDSSFMQYLPSVMANATMLHVVQN 269
FL Y + K FL LS I +++YLPSV+A A H+
Sbjct: 139 NQFLTQYFLHQQPANCKVESLAMFLGE-----LSLIDADPYLKYLPSVIAGAA-FHLA-- 190
Query: 270 IESSLGVEYEKQLLNILGTDKDKVEHCSKLIMQLAEQVQGQGSQSIKRKF 319
+ + G + + L+ G + ++ C + Q + QSI+ K+
Sbjct: 191 LYTVTGQSWPESLIRKTGYTLESLKPCLMDLHQTYLKAPQHAQQSIREKY 240
>pdb|1JST|B Chain B, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A
pdb|1JST|D Chain D, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A
pdb|1GY3|B Chain B, Pcdk2CYCLIN A IN COMPLEX WITH MGADP, NITRATE AND PEPTIDE
SUBSTRATE
pdb|1GY3|D Chain D, Pcdk2CYCLIN A IN COMPLEX WITH MGADP, NITRATE AND PEPTIDE
SUBSTRATE
pdb|1H1P|B Chain B, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu2058
pdb|1H1P|D Chain D, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu2058
pdb|1H1Q|B Chain B, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu6094
pdb|1H1Q|D Chain D, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu6094
pdb|1H1R|B Chain B, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu6086
pdb|1H1R|D Chain D, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu6086
pdb|1H1S|B Chain B, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu6102
pdb|1H1S|D Chain D, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu6102
pdb|1P5E|B Chain B, The Strucure Of Phospho-Cdk2CYCLIN A IN COMPLEX WITH THE
Inhibitor 4,5,6,7-Tetrabromobenzotriazole (Tbs)
pdb|1P5E|D Chain D, The Strucure Of Phospho-Cdk2CYCLIN A IN COMPLEX WITH THE
Inhibitor 4,5,6,7-Tetrabromobenzotriazole (Tbs)
pdb|1PKD|B Chain B, The Crystal Structure Of Ucn-01 In Complex With Phospho-
Cdk2CYCLIN A
pdb|1PKD|D Chain D, The Crystal Structure Of Ucn-01 In Complex With Phospho-
Cdk2CYCLIN A
pdb|2C6T|B Chain B, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2C6T|D Chain D, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2CJM|B Chain B, Mechanism Of Cdk Inhibition By Active Site
Phosphorylation: Cdk2 Y15p T160p In Complex With Cyclin
A Structure
pdb|2CJM|D Chain D, Mechanism Of Cdk Inhibition By Active Site
Phosphorylation: Cdk2 Y15p T160p In Complex With Cyclin
A Structure
pdb|2CCI|B Chain B, Crystal Structure Of Phospho-Cdk2 Cyclin A In Complex With
A Peptide Containing Both The Substrate And Recruitment
Sites Of Cdc6
pdb|2CCI|D Chain D, Crystal Structure Of Phospho-Cdk2 Cyclin A In Complex With
A Peptide Containing Both The Substrate And Recruitment
Sites Of Cdc6
pdb|2UZB|B Chain B, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZB|D Chain D, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZD|B Chain B, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZD|D Chain D, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZE|B Chain B, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZE|D Chain D, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZL|B Chain B, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZL|D Chain D, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|4EOI|B Chain B, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3
Complex With The Inhibitor Ro3306
pdb|4EOI|D Chain D, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3
Complex With The Inhibitor Ro3306
pdb|4EOJ|B Chain B, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human
Cyclin A3 Complex With Atp
pdb|4EOJ|D Chain D, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human
Cyclin A3 Complex With Atp
pdb|4EOK|B Chain B, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human
Cyclin A3 Complex With The Inhibitor Nu6102
pdb|4EOK|D Chain D, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human
Cyclin A3 Complex With The Inhibitor Nu6102
pdb|4EOL|B Chain B, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human
Cyclin A3 Complex With The Inhibitor Ro3306
pdb|4EOL|D Chain D, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human
Cyclin A3 Complex With The Inhibitor Ro3306
pdb|4EOM|B Chain B, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human
Cyclin A3 Complex With Atp
pdb|4EOM|D Chain D, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human
Cyclin A3 Complex With Atp
pdb|4EON|B Chain B, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human
Cyclin A3 Complex With The Inhibitor Ro3306
pdb|4EON|D Chain D, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human
Cyclin A3 Complex With The Inhibitor Ro3306
pdb|4EOO|B Chain B, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3
Complex With Atp
pdb|4EOO|D Chain D, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3
Complex With Atp
pdb|4EOP|B Chain B, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3
Complex With The Inhibitor Ro3306
pdb|4EOP|D Chain D, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3
Complex With The Inhibitor Ro3306
pdb|4EOQ|B Chain B, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
With Atp
pdb|4EOQ|D Chain D, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
With Atp
pdb|4EOR|B Chain B, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
With The Inhibitor Nu6102
pdb|4EOR|D Chain D, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
With The Inhibitor Nu6102
pdb|4EOS|B Chain B, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
With The Inhibitor Ro3306
pdb|4EOS|D Chain D, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
With The Inhibitor Ro3306
Length = 258
Score = 66.6 bits (161), Expect = 2e-11, Method: Compositional matrix adjust.
Identities = 66/230 (28%), Positives = 104/230 (45%), Gaps = 24/230 (10%)
Query: 98 LKTNPSLSRA-RSEAVDWMLKVNAHYSFTALTALLAVNYLDRFLFSFQLQRDKPWMAQLA 156
+K P ++ + R+ VDW+++V Y T LAVNY+DRFL S + R K QL
Sbjct: 26 MKKQPDITNSMRAILVDWLVEVGEEYKLQNETLHLAVNYIDRFLSSMSVLRGK---LQLV 82
Query: 157 AVACLSLAAKVEETQVPLLLDLQVEDIKFV----FEAKTIQRMEILVLSTLQWKMNPVTP 212
A + LA+K EE P +V + ++ + K + RME LVL L + + T
Sbjct: 83 GTAAMLLASKFEEIYPP-----EVAEFVYITDDTYTKKQVLRMEHLVLKVLTFDLAAPTV 137
Query: 213 LSFL-DYIARR--LGLKGYLCWEFLKRCDRILLSAISDSSFMQYLPSVMANATMLHVVQN 269
FL Y + K FL LS I +++YLPSV+A A H+
Sbjct: 138 NQFLTQYFLHQQPANCKVESLAMFLGE-----LSLIDADPYLKYLPSVIAGAA-FHLA-- 189
Query: 270 IESSLGVEYEKQLLNILGTDKDKVEHCSKLIMQLAEQVQGQGSQSIKRKF 319
+ + G + + L+ G + ++ C + Q + QSI+ K+
Sbjct: 190 LYTVTGQSWPESLIRKTGYTLESLKPCLMDLHQTYLKAPQHAQQSIREKY 239
>pdb|1OGU|B Chain B, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed
With A
2-arylamino-4-cyclohexylmethyl-5-nitroso-6-
aminopyrimidine Inhibitor
pdb|1OGU|D Chain D, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed
With A
2-arylamino-4-cyclohexylmethyl-5-nitroso-6-
aminopyrimidine Inhibitor
pdb|1OI9|B Chain B, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
pdb|1OI9|D Chain D, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
pdb|1OIU|B Chain B, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
pdb|1OIU|D Chain D, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
pdb|1OIY|B Chain B, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
pdb|1OIY|D Chain D, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
pdb|2IW6|B Chain B, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed
With A Bisanilinopyrimidine Inhibitor
pdb|2IW6|D Chain D, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed
With A Bisanilinopyrimidine Inhibitor
pdb|2IW8|B Chain B, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v-
H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor
pdb|2IW8|D Chain D, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v-
H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor
pdb|2IW9|B Chain B, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed
With A Bisanilinopyrimidine Inhibitor
pdb|2IW9|D Chain D, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed
With A Bisanilinopyrimidine Inhibitor
Length = 260
Score = 66.6 bits (161), Expect = 2e-11, Method: Compositional matrix adjust.
Identities = 66/230 (28%), Positives = 104/230 (45%), Gaps = 24/230 (10%)
Query: 98 LKTNPSLSRA-RSEAVDWMLKVNAHYSFTALTALLAVNYLDRFLFSFQLQRDKPWMAQLA 156
+K P ++ + R+ VDW+++V Y T LAVNY+DRFL S + R K QL
Sbjct: 28 MKKQPDITNSMRAILVDWLVEVGEEYKLQNETLHLAVNYIDRFLSSMSVLRGK---LQLV 84
Query: 157 AVACLSLAAKVEETQVPLLLDLQVEDIKFV----FEAKTIQRMEILVLSTLQWKMNPVTP 212
A + LA+K EE P +V + ++ + K + RME LVL L + + T
Sbjct: 85 GTAAMLLASKFEEIYPP-----EVAEFVYITDDTYTKKQVLRMEHLVLKVLTFDLAAPTV 139
Query: 213 LSFL-DYIARR--LGLKGYLCWEFLKRCDRILLSAISDSSFMQYLPSVMANATMLHVVQN 269
FL Y + K FL LS I +++YLPSV+A A H+
Sbjct: 140 NQFLTQYFLHQQPANCKVESLAMFLGE-----LSLIDADPYLKYLPSVIAGAA-FHLA-- 191
Query: 270 IESSLGVEYEKQLLNILGTDKDKVEHCSKLIMQLAEQVQGQGSQSIKRKF 319
+ + G + + L+ G + ++ C + Q + QSI+ K+
Sbjct: 192 LYTVTGQSWPESLIRKTGYTLESLKPCLMDLHQTYLKAPQHAQQSIREKY 241
>pdb|2X1N|B Chain B, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|2X1N|D Chain D, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
Length = 261
Score = 66.6 bits (161), Expect = 2e-11, Method: Compositional matrix adjust.
Identities = 66/230 (28%), Positives = 104/230 (45%), Gaps = 24/230 (10%)
Query: 98 LKTNPSLSRA-RSEAVDWMLKVNAHYSFTALTALLAVNYLDRFLFSFQLQRDKPWMAQLA 156
+K P ++ + R+ VDW+++V Y T LAVNY+DRFL S + R K QL
Sbjct: 29 MKKQPDITNSMRAILVDWLVEVGEEYKLQNETLHLAVNYIDRFLSSMSVLRGK---LQLV 85
Query: 157 AVACLSLAAKVEETQVPLLLDLQVEDIKFV----FEAKTIQRMEILVLSTLQWKMNPVTP 212
A + LA+K EE P +V + ++ + K + RME LVL L + + T
Sbjct: 86 GTAAMLLASKFEEIYPP-----EVAEFVYITDDTYTKKQVLRMEHLVLKVLTFDLAAPTV 140
Query: 213 LSFL-DYIARR--LGLKGYLCWEFLKRCDRILLSAISDSSFMQYLPSVMANATMLHVVQN 269
FL Y + K FL LS I +++YLPSV+A A H+
Sbjct: 141 NQFLTQYFLHQQPANCKVESLAMFLGE-----LSLIDADPYLKYLPSVIAGAA-FHLA-- 192
Query: 270 IESSLGVEYEKQLLNILGTDKDKVEHCSKLIMQLAEQVQGQGSQSIKRKF 319
+ + G + + L+ G + ++ C + Q + QSI+ K+
Sbjct: 193 LYTVTGQSWPESLIRKTGYTLESLKPCLMDLHQTYLKAPQHAQQSIREKY 242
>pdb|1FIN|B Chain B, Cyclin A-Cyclin-Dependent Kinase 2 Complex
pdb|1FIN|D Chain D, Cyclin A-Cyclin-Dependent Kinase 2 Complex
pdb|1JSU|B Chain B, P27(Kip1)CYCLIN ACDK2 COMPLEX
pdb|1FVV|B Chain B, The Structure Of Cdk2CYCLIN A IN COMPLEX WITH AN OXINDOLE
Inhibitor
pdb|1FVV|D Chain D, The Structure Of Cdk2CYCLIN A IN COMPLEX WITH AN OXINDOLE
Inhibitor
pdb|1OKV|B Chain B, Cyclin A Binding Groove Inhibitor
H-Arg-Arg-Leu-Ile-Phe-Nh2
pdb|1OKV|D Chain D, Cyclin A Binding Groove Inhibitor
H-Arg-Arg-Leu-Ile-Phe-Nh2
pdb|1OKW|B Chain B, Cyclin A Binding Groove Inhibitor
Ac-Arg-Arg-Leu-Asn-(M-Cl-Phe)-Nh2
pdb|1OKW|D Chain D, Cyclin A Binding Groove Inhibitor
Ac-Arg-Arg-Leu-Asn-(M-Cl-Phe)-Nh2
pdb|1OL1|B Chain B, Cyclin A Binding Groove Inhibitor
H-Cit-Cit-Leu-Ile-(P-F-Phe)-Nh2
pdb|1OL1|D Chain D, Cyclin A Binding Groove Inhibitor
H-Cit-Cit-Leu-Ile-(P-F-Phe)-Nh2
pdb|1OL2|B Chain B, Cyclin A Binding Groove Inhibitor
H-Arg-Arg-Leu-Asn-(P-F-Phe)-Nh2
pdb|1OL2|D Chain D, Cyclin A Binding Groove Inhibitor
H-Arg-Arg-Leu-Asn-(P-F-Phe)-Nh2
pdb|1URC|B Chain B, Cyclin A Binding Groove Inhibitor Ace-Arg-Lys-Leu- Phe-Gly
pdb|1URC|D Chain D, Cyclin A Binding Groove Inhibitor Ace-Arg-Lys-Leu- Phe-Gly
pdb|2C5O|B Chain B, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5O|D Chain D, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2CCH|B Chain B, The Crystal Structure Of Cdk2 Cyclin A In Complex With A
Substrate Peptide Derived From Cdc Modified With A
Gamma- Linked Atp Analogue
pdb|2CCH|D Chain D, The Crystal Structure Of Cdk2 Cyclin A In Complex With A
Substrate Peptide Derived From Cdc Modified With A
Gamma- Linked Atp Analogue
pdb|2I40|B Chain B, Cdk2CYCLIN A COMPLEXED WITH A THIOPHENE CARBOXAMIDE
INHIBITOR
pdb|2I40|D Chain D, Cdk2CYCLIN A COMPLEXED WITH A THIOPHENE CARBOXAMIDE
INHIBITOR
pdb|3EID|B Chain B, Cdk2CYCLINA COMPLEXED WITH A PYRAZOLOPYRIDAZINE INHIBITOR
pdb|3EID|D Chain D, Cdk2CYCLINA COMPLEXED WITH A PYRAZOLOPYRIDAZINE INHIBITOR
pdb|3EJ1|B Chain B, Cdk2CYCLINA COMPLEXED WITH A PYRAZOLOPYRIDAZINE INHIBITOR
pdb|3EJ1|D Chain D, Cdk2CYCLINA COMPLEXED WITH A PYRAZOLOPYRIDAZINE INHIBITOR
pdb|3EOC|B Chain B, Cdk2/cyclina Complexed With A Imidazo Triazin-2-amine
pdb|3EOC|D Chain D, Cdk2/cyclina Complexed With A Imidazo Triazin-2-amine
pdb|2WEV|B Chain B, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|2WEV|D Chain D, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|2WFY|B Chain B, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|2WFY|D Chain D, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|2WHB|B Chain B, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|2WHB|D Chain D, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
Length = 260
Score = 66.6 bits (161), Expect = 2e-11, Method: Compositional matrix adjust.
Identities = 66/230 (28%), Positives = 104/230 (45%), Gaps = 24/230 (10%)
Query: 98 LKTNPSLSRA-RSEAVDWMLKVNAHYSFTALTALLAVNYLDRFLFSFQLQRDKPWMAQLA 156
+K P ++ + R+ VDW+++V Y T LAVNY+DRFL S + R K QL
Sbjct: 28 MKKQPDITNSMRAILVDWLVEVGEEYKLQNETLHLAVNYIDRFLSSMSVLRGK---LQLV 84
Query: 157 AVACLSLAAKVEETQVPLLLDLQVEDIKFV----FEAKTIQRMEILVLSTLQWKMNPVTP 212
A + LA+K EE P +V + ++ + K + RME LVL L + + T
Sbjct: 85 GTAAMLLASKFEEIYPP-----EVAEFVYITDDTYTKKQVLRMEHLVLKVLTFDLAAPTV 139
Query: 213 LSFL-DYIARR--LGLKGYLCWEFLKRCDRILLSAISDSSFMQYLPSVMANATMLHVVQN 269
FL Y + K FL LS I +++YLPSV+A A H+
Sbjct: 140 NQFLTQYFLHQQPANCKVESLAMFLGE-----LSLIDADPYLKYLPSVIAGAA-FHLA-- 191
Query: 270 IESSLGVEYEKQLLNILGTDKDKVEHCSKLIMQLAEQVQGQGSQSIKRKF 319
+ + G + + L+ G + ++ C + Q + QSI+ K+
Sbjct: 192 LYTVTGQSWPESLIRKTGYTLESLKPCLMDLHQTYLKAPQHAQQSIREKY 241
>pdb|1E9H|B Chain B, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With
The Inhibitor Indirubin-5-Sulphonate Bound
pdb|1E9H|D Chain D, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With
The Inhibitor Indirubin-5-Sulphonate Bound
Length = 261
Score = 66.6 bits (161), Expect = 3e-11, Method: Compositional matrix adjust.
Identities = 66/230 (28%), Positives = 104/230 (45%), Gaps = 24/230 (10%)
Query: 98 LKTNPSLSRA-RSEAVDWMLKVNAHYSFTALTALLAVNYLDRFLFSFQLQRDKPWMAQLA 156
+K P ++ + R+ VDW+++V Y T LAVNY+DRFL S + R K QL
Sbjct: 26 MKKQPDITNSMRAILVDWLVEVGEEYKLQNETLHLAVNYIDRFLSSMSVLRGK---LQLV 82
Query: 157 AVACLSLAAKVEETQVPLLLDLQVEDIKFV----FEAKTIQRMEILVLSTLQWKMNPVTP 212
A + LA+K EE P +V + ++ + K + RME LVL L + + T
Sbjct: 83 GTAAMLLASKFEEIYPP-----EVAEFVYITDDTYTKKQVLRMEHLVLKVLTFDLAAPTV 137
Query: 213 LSFL-DYIARR--LGLKGYLCWEFLKRCDRILLSAISDSSFMQYLPSVMANATMLHVVQN 269
FL Y + K FL LS I +++YLPSV+A A H+
Sbjct: 138 NQFLTQYFLHQQPANCKVESLAMFLGE-----LSLIDADPYLKYLPSVIAGAA-FHLA-- 189
Query: 270 IESSLGVEYEKQLLNILGTDKDKVEHCSKLIMQLAEQVQGQGSQSIKRKF 319
+ + G + + L+ G + ++ C + Q + QSI+ K+
Sbjct: 190 LYTVTGQSWPESLIRKTGYTLESLKPCLMDLHQTYLKAPQHAQQSIREKY 239
>pdb|3F5X|B Chain B, Cdk-2-Cyclin Complex With Indazole Inhibitor 9 Bound At
Its Active Site
pdb|3F5X|D Chain D, Cdk-2-Cyclin Complex With Indazole Inhibitor 9 Bound At
Its Active Site
Length = 256
Score = 66.2 bits (160), Expect = 3e-11, Method: Compositional matrix adjust.
Identities = 66/230 (28%), Positives = 104/230 (45%), Gaps = 24/230 (10%)
Query: 98 LKTNPSLSRA-RSEAVDWMLKVNAHYSFTALTALLAVNYLDRFLFSFQLQRDKPWMAQLA 156
+K P ++ + R+ VDW+++V Y T LAVNY+DRFL S + R K QL
Sbjct: 24 MKKQPDITNSMRAILVDWLVEVGEEYKLQNETLHLAVNYIDRFLSSMSVLRGK---LQLV 80
Query: 157 AVACLSLAAKVEETQVPLLLDLQVEDIKFV----FEAKTIQRMEILVLSTLQWKMNPVTP 212
A + LA+K EE P +V + ++ + K + RME LVL L + + T
Sbjct: 81 GTAAMLLASKFEEIYPP-----EVAEFVYITDDTYTKKQVLRMEHLVLKVLTFDLAAPTV 135
Query: 213 LSFL-DYIARR--LGLKGYLCWEFLKRCDRILLSAISDSSFMQYLPSVMANATMLHVVQN 269
FL Y + K FL LS I +++YLPSV+A A H+
Sbjct: 136 NQFLTQYFLHQQPANCKVESLAMFLGE-----LSLIDADPYLKYLPSVIAGAA-FHLA-- 187
Query: 270 IESSLGVEYEKQLLNILGTDKDKVEHCSKLIMQLAEQVQGQGSQSIKRKF 319
+ + G + + L+ G + ++ C + Q + QSI+ K+
Sbjct: 188 LYTVTGQSWPESLIRKTGYTLESLKPCLMDLHQTYLKAPQHAQQSIREKY 237
>pdb|4BCO|B Chain B, Structure Of Cdk2 In Complex With Cyclin A And A
2-amino-4- Heteroaryl-pyrimidine Inhibitor
pdb|4BCO|D Chain D, Structure Of Cdk2 In Complex With Cyclin A And A
2-amino-4- Heteroaryl-pyrimidine Inhibitor
Length = 262
Score = 65.9 bits (159), Expect = 4e-11, Method: Compositional matrix adjust.
Identities = 66/230 (28%), Positives = 104/230 (45%), Gaps = 24/230 (10%)
Query: 98 LKTNPSLSRA-RSEAVDWMLKVNAHYSFTALTALLAVNYLDRFLFSFQLQRDKPWMAQLA 156
+K P ++ + R+ VDW+++V Y T LAVNY+DRFL S + R K QL
Sbjct: 30 MKKQPDITNSMRAILVDWLVEVGEEYKLQNETLHLAVNYIDRFLSSMSVLRGK---LQLV 86
Query: 157 AVACLSLAAKVEETQVPLLLDLQVEDIKFV----FEAKTIQRMEILVLSTLQWKMNPVTP 212
A + LA+K EE P +V + ++ + K + RME LVL L + + T
Sbjct: 87 GTAAMLLASKFEEIYPP-----EVAEFVYITDDTYTKKQVLRMEHLVLKVLTFDLAAPTV 141
Query: 213 LSFL-DYIARR--LGLKGYLCWEFLKRCDRILLSAISDSSFMQYLPSVMANATMLHVVQN 269
FL Y + K FL LS I +++YLPSV+A A H+
Sbjct: 142 NQFLTQYFLHQQPANCKVESLAMFLGE-----LSLIDADPYLKYLPSVIA-AAAFHLA-- 193
Query: 270 IESSLGVEYEKQLLNILGTDKDKVEHCSKLIMQLAEQVQGQGSQSIKRKF 319
+ + G + + L+ G + ++ C + Q + QSI+ K+
Sbjct: 194 LYTVTGQSWPESLIRKTGYTLESLKPCLMDLHQTYLKAPQHAQQSIREKY 243
>pdb|3DOG|B Chain B, Structure Of Thr 160 Phosphorylated Cdk2CYCLIN A IN
Complex With The Inhibitor N-&-N1
pdb|3DOG|D Chain D, Structure Of Thr 160 Phosphorylated Cdk2CYCLIN A IN
Complex With The Inhibitor N-&-N1
Length = 264
Score = 64.7 bits (156), Expect = 9e-11, Method: Compositional matrix adjust.
Identities = 66/230 (28%), Positives = 104/230 (45%), Gaps = 24/230 (10%)
Query: 98 LKTNPSLSRA-RSEAVDWMLKVNAHYSFTALTALLAVNYLDRFLFSFQLQRDKPWMAQLA 156
+K P ++ + R+ VDW+++V Y T LAVNY+DRFL S + R K QL
Sbjct: 30 MKKQPDITNSMRAILVDWLVEVGEEYKLQNETLHLAVNYIDRFLSSMSVLRGK---LQLV 86
Query: 157 AVACLSLAAKVEETQVPLLLDLQVEDIKFV----FEAKTIQRMEILVLSTLQWKMNPVTP 212
A + LA+K EE P +V + ++ + K + RME LVL L + + T
Sbjct: 87 GTAAMLLASKFEEIYPP-----EVAEFVYITDDTYTKKQVLRMEHLVLKVLAFDLAAPTI 141
Query: 213 LSFL-DYIARR--LGLKGYLCWEFLKRCDRILLSAISDSSFMQYLPSVMANATMLHVVQN 269
FL Y + K FL LS I +++YLPSV+A A H+
Sbjct: 142 NQFLTQYFLHQQPANCKVESLAMFLGE-----LSLIDADPYLKYLPSVIA-AAAFHLA-- 193
Query: 270 IESSLGVEYEKQLLNILGTDKDKVEHCSKLIMQLAEQVQGQGSQSIKRKF 319
+ + G + + L+ G + ++ C + Q + QSI+ K+
Sbjct: 194 LYTVTGQSWPESLVQKTGYTLETLKPCLLDLHQTYLRAPQHAQQSIREKY 243
>pdb|2G9X|B Chain B, Structure Of Thr 160 Phosphorylated Cdk2CYCLIN A IN
COMPLEX WITH THE Inhibitor Nu6271
pdb|2G9X|D Chain D, Structure Of Thr 160 Phosphorylated Cdk2CYCLIN A IN
COMPLEX WITH THE Inhibitor Nu6271
Length = 262
Score = 64.7 bits (156), Expect = 9e-11, Method: Compositional matrix adjust.
Identities = 66/230 (28%), Positives = 104/230 (45%), Gaps = 24/230 (10%)
Query: 98 LKTNPSLSRA-RSEAVDWMLKVNAHYSFTALTALLAVNYLDRFLFSFQLQRDKPWMAQLA 156
+K P ++ + R+ VDW+++V Y T LAVNY+DRFL S + R K QL
Sbjct: 30 MKKQPDITNSMRAILVDWLVEVGEEYKLQNETLHLAVNYIDRFLSSMSVLRGK---LQLV 86
Query: 157 AVACLSLAAKVEETQVPLLLDLQVEDIKFV----FEAKTIQRMEILVLSTLQWKMNPVTP 212
A + LA+K EE P +V + ++ + K + RME LVL L + + T
Sbjct: 87 GTAAMLLASKFEEIYPP-----EVAEFVYITDDTYTKKQVLRMEHLVLKVLAFDLAAPTI 141
Query: 213 LSFL-DYIARR--LGLKGYLCWEFLKRCDRILLSAISDSSFMQYLPSVMANATMLHVVQN 269
FL Y + K FL LS I +++YLPSV+A A H+
Sbjct: 142 NQFLTQYFLHQQPANCKVESLAMFLGE-----LSLIDADPYLKYLPSVIA-AAAFHLA-- 193
Query: 270 IESSLGVEYEKQLLNILGTDKDKVEHCSKLIMQLAEQVQGQGSQSIKRKF 319
+ + G + + L+ G + ++ C + Q + QSI+ K+
Sbjct: 194 LYTVTGQSWPESLVQKTGYTLETLKPCLLDLHQTYLRAPQHAQQSIREKY 243
>pdb|1VIN|A Chain A, Bovine Cyclin A3
Length = 268
Score = 64.7 bits (156), Expect = 9e-11, Method: Compositional matrix adjust.
Identities = 66/230 (28%), Positives = 104/230 (45%), Gaps = 24/230 (10%)
Query: 98 LKTNPSLSRA-RSEAVDWMLKVNAHYSFTALTALLAVNYLDRFLFSFQLQRDKPWMAQLA 156
+K P ++ + R+ VDW+++V Y T LAVNY+DRFL S + R K QL
Sbjct: 30 MKKQPDITNSMRAILVDWLVEVGEEYKLQNETLHLAVNYIDRFLSSMSVLRGK---LQLV 86
Query: 157 AVACLSLAAKVEETQVPLLLDLQVEDIKFV----FEAKTIQRMEILVLSTLQWKMNPVTP 212
A + LA+K EE P +V + ++ + K + RME LVL L + + T
Sbjct: 87 GTAAMLLASKFEEIYPP-----EVAEFVYITDDTYTKKQVLRMEHLVLKVLAFDLAAPTI 141
Query: 213 LSFL-DYIARR--LGLKGYLCWEFLKRCDRILLSAISDSSFMQYLPSVMANATMLHVVQN 269
FL Y + K FL LS I +++YLPSV+A A H+
Sbjct: 142 NQFLTQYFLHQQPANCKVESLAMFLGE-----LSLIDADPYLKYLPSVIA-AAAFHLA-- 193
Query: 270 IESSLGVEYEKQLLNILGTDKDKVEHCSKLIMQLAEQVQGQGSQSIKRKF 319
+ + G + + L+ G + ++ C + Q + QSI+ K+
Sbjct: 194 LYTVTGQSWPESLVQKTGYTLETLKPCLLDLHQTYLRAPQHAQQSIREKY 243
>pdb|4BCQ|B Chain B, Structure Of Cdk2 In Complex With Cyclin A And A
2-amino-4- Heteroaryl-pyrimidine Inhibitor
Length = 262
Score = 64.7 bits (156), Expect = 9e-11, Method: Compositional matrix adjust.
Identities = 66/230 (28%), Positives = 103/230 (44%), Gaps = 24/230 (10%)
Query: 98 LKTNPSLSRA-RSEAVDWMLKVNAHYSFTALTALLAVNYLDRFLFSFQLQRDKPWMAQLA 156
+K P ++ + R+ VDW+++V Y T LAVNY+DRFL S + R K QL
Sbjct: 30 MKKQPDITNSMRAILVDWLVEVGEEYKLQNETLHLAVNYIDRFLSSMSVLRGK---LQLV 86
Query: 157 AVACLSLAAKVEETQVPLLLDLQVEDIKFV----FEAKTIQRMEILVLSTLQWKMNPVTP 212
A + LA+K EE P +V + ++ + K + RME LVL L + + T
Sbjct: 87 GTAAMLLASKFEEIYPP-----EVAEFVYITDDTYTKKQVLRMEHLVLKVLTFDLAAPTV 141
Query: 213 LSFL-DYIARR--LGLKGYLCWEFLKRCDRILLSAISDSSFMQYLPSVMANATMLHVVQN 269
FL Y + K FL LS I +++YLPSV+A A H+
Sbjct: 142 NQFLTQYFLHQQPANCKVESLAMFLGE-----LSLIDADPYLKYLPSVIA-AAAFHLA-- 193
Query: 270 IESSLGVEYEKQLLNILGTDKDKVEHCSKLIMQLAEQVQGQGSQSIKRKF 319
+ + G + + L+ G + + C + Q + QSI+ K+
Sbjct: 194 LYTVTGQSWPESLIRKTGYTLETSKPCMLDLHQTYLKAPQHAQQSIREKY 243
>pdb|3DDQ|B Chain B, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
With The Inhibitor Roscovitine
pdb|3DDQ|D Chain D, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
With The Inhibitor Roscovitine
Length = 269
Score = 64.3 bits (155), Expect = 1e-10, Method: Compositional matrix adjust.
Identities = 66/230 (28%), Positives = 104/230 (45%), Gaps = 24/230 (10%)
Query: 98 LKTNPSLSRA-RSEAVDWMLKVNAHYSFTALTALLAVNYLDRFLFSFQLQRDKPWMAQLA 156
+K P ++ + R+ VDW+++V Y T LAVNY+DRFL S + R K QL
Sbjct: 30 MKKQPDITNSMRAILVDWLVEVGEEYKLQNETLHLAVNYIDRFLSSMSVLRGK---LQLV 86
Query: 157 AVACLSLAAKVEETQVPLLLDLQVEDIKFV----FEAKTIQRMEILVLSTLQWKMNPVTP 212
A + LA+K EE P +V + ++ + K + RME LVL L + + T
Sbjct: 87 GTAAMLLASKFEEIYPP-----EVAEFVYITDDTYTKKQVLRMEHLVLKVLAFDLAAPTI 141
Query: 213 LSFL-DYIARR--LGLKGYLCWEFLKRCDRILLSAISDSSFMQYLPSVMANATMLHVVQN 269
FL Y + K FL LS I +++YLPSV+A A H+
Sbjct: 142 NQFLTQYFLHQQPANCKVESLAMFLGE-----LSLIDADPYLKYLPSVIA-AAAFHLA-- 193
Query: 270 IESSLGVEYEKQLLNILGTDKDKVEHCSKLIMQLAEQVQGQGSQSIKRKF 319
+ + G + + L+ G + ++ C + Q + QSI+ K+
Sbjct: 194 LYTVTGQSWPESLVQKTGYTLETLKPCLLDLHQTYLRAPQHAQQSIREKY 243
>pdb|3DDP|B Chain B, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
With The Inhibitor Cr8
pdb|3DDP|D Chain D, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
With The Inhibitor Cr8
Length = 268
Score = 64.3 bits (155), Expect = 1e-10, Method: Compositional matrix adjust.
Identities = 66/230 (28%), Positives = 104/230 (45%), Gaps = 24/230 (10%)
Query: 98 LKTNPSLSRA-RSEAVDWMLKVNAHYSFTALTALLAVNYLDRFLFSFQLQRDKPWMAQLA 156
+K P ++ + R+ VDW+++V Y T LAVNY+DRFL S + R K QL
Sbjct: 30 MKKQPDITNSMRAILVDWLVEVGEEYKLQNETLHLAVNYIDRFLSSMSVLRGK---LQLV 86
Query: 157 AVACLSLAAKVEETQVPLLLDLQVEDIKFV----FEAKTIQRMEILVLSTLQWKMNPVTP 212
A + LA+K EE P +V + ++ + K + RME LVL L + + T
Sbjct: 87 GTAAMLLASKFEEIYPP-----EVAEFVYITDDTYTKKQVLRMEHLVLKVLAFDLAAPTI 141
Query: 213 LSFL-DYIARR--LGLKGYLCWEFLKRCDRILLSAISDSSFMQYLPSVMANATMLHVVQN 269
FL Y + K FL LS I +++YLPSV+A A H+
Sbjct: 142 NQFLTQYFLHQQPANCKVESLAMFLGE-----LSLIDADPYLKYLPSVIA-AAAFHLA-- 193
Query: 270 IESSLGVEYEKQLLNILGTDKDKVEHCSKLIMQLAEQVQGQGSQSIKRKF 319
+ + G + + L+ G + ++ C + Q + QSI+ K+
Sbjct: 194 LYTVTGQSWPESLVQKTGYTLETLKPCLLDLHQTYLRAPQHAQQSIREKY 243
>pdb|3BHT|B Chain B, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
WITH THE Inhibitor Meriolin 3
pdb|3BHT|D Chain D, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
WITH THE Inhibitor Meriolin 3
pdb|3BHU|B Chain B, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
WITH THE Inhibitor Meriolin 5
pdb|3BHU|D Chain D, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
WITH THE Inhibitor Meriolin 5
pdb|3BHV|B Chain B, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
With The Inhibitor Variolin B
pdb|3BHV|D Chain D, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
With The Inhibitor Variolin B
pdb|3MY5|B Chain B, Cdk2CYCLINA IN COMPLEX WITH DRB
pdb|3MY5|D Chain D, Cdk2CYCLINA IN COMPLEX WITH DRB
pdb|3TNW|B Chain B, Structure Of Cdk2CYCLIN A IN COMPLEX WITH CAN508
pdb|3TNW|D Chain D, Structure Of Cdk2CYCLIN A IN COMPLEX WITH CAN508
Length = 262
Score = 64.3 bits (155), Expect = 1e-10, Method: Compositional matrix adjust.
Identities = 66/230 (28%), Positives = 104/230 (45%), Gaps = 24/230 (10%)
Query: 98 LKTNPSLSRA-RSEAVDWMLKVNAHYSFTALTALLAVNYLDRFLFSFQLQRDKPWMAQLA 156
+K P ++ + R+ VDW+++V Y T LAVNY+DRFL S + R K QL
Sbjct: 30 MKKQPDITNSMRAILVDWLVEVGEEYKLQNETLHLAVNYIDRFLSSMSVLRGK---LQLV 86
Query: 157 AVACLSLAAKVEETQVPLLLDLQVEDIKFV----FEAKTIQRMEILVLSTLQWKMNPVTP 212
A + LA+K EE P +V + ++ + K + RME LVL L + + T
Sbjct: 87 GTAAMLLASKFEEIYPP-----EVAEFVYITDDTYTKKQVLRMEHLVLKVLAFDLAAPTI 141
Query: 213 LSFL-DYIARR--LGLKGYLCWEFLKRCDRILLSAISDSSFMQYLPSVMANATMLHVVQN 269
FL Y + K FL LS I +++YLPSV+A A H+
Sbjct: 142 NQFLTQYFLHQQPANCKVESLAMFLGE-----LSLIDADPYLKYLPSVIA-AAAFHLA-- 193
Query: 270 IESSLGVEYEKQLLNILGTDKDKVEHCSKLIMQLAEQVQGQGSQSIKRKF 319
+ + G + + L+ G + ++ C + Q + QSI+ K+
Sbjct: 194 LYTVTGQSWPESLVQKTGYTLETLKPCLLDLHQTYLRAPQHAQQSIREKY 243
>pdb|4I3Z|B Chain B, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM
IONS
pdb|4I3Z|D Chain D, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM
IONS
Length = 257
Score = 63.9 bits (154), Expect = 1e-10, Method: Compositional matrix adjust.
Identities = 70/252 (27%), Positives = 111/252 (44%), Gaps = 25/252 (9%)
Query: 77 WQDDELSTLLSKEVPNR-LYNILKTNPSLSRA-RSEAVDWMLKVNAHYSFTALTALLAVN 134
+Q+D + L EV + +K P ++ + R+ VDW+++V Y T LAVN
Sbjct: 4 YQEDIHTYLREMEVKCKPKVGYMKRQPDITNSMRAILVDWLVEVGEEYKLQNETLHLAVN 63
Query: 135 YLDRFLFSFQLQRDKPWMAQLAAVACLSLAAKVEETQVPLLLDLQVEDIKFV----FEAK 190
Y+DRFL S + R K QL A + LA+K EE P +V + ++ + K
Sbjct: 64 YIDRFLSSMSVLRGK---LQLVGTAAMLLASKFEEIYPP-----EVAEFVYITDDTYSKK 115
Query: 191 TIQRMEILVLSTLQWKMNPVTPLSFLDYIARRL---GLKGYLCWEFLKRCDRILLSAISD 247
+ RME LVL L + + T FL L K FL LS I
Sbjct: 116 QVLRMEHLVLKVLAFDLAAPTVNQFLTQYFLHLQPANCKVESLAMFLGE-----LSLIDA 170
Query: 248 SSFMQYLPSVMANATMLHVVQNIESSLGVEYEKQLLNILGTDKDKVEHCSKLIMQLAEQV 307
+++YLPS++A A H+ + + G + + L G + ++ C + Q +
Sbjct: 171 DPYLKYLPSLIAGAA-FHLA--LYTVTGQSWPESLAQQTGYTLESLKPCLVDLHQTYLKA 227
Query: 308 QGQGSQSIKRKF 319
QSI+ K+
Sbjct: 228 PQHAQQSIREKY 239
>pdb|4II5|B Chain B, Structure Of Pcdk2/cyclina Bound To Adp And 1 Magnesium
Ion
pdb|4II5|D Chain D, Structure Of Pcdk2/cyclina Bound To Adp And 1 Magnesium
Ion
Length = 258
Score = 63.9 bits (154), Expect = 1e-10, Method: Compositional matrix adjust.
Identities = 70/252 (27%), Positives = 111/252 (44%), Gaps = 25/252 (9%)
Query: 77 WQDDELSTLLSKEVPNR-LYNILKTNPSLSRA-RSEAVDWMLKVNAHYSFTALTALLAVN 134
+Q+D + L EV + +K P ++ + R+ VDW+++V Y T LAVN
Sbjct: 4 YQEDIHTYLREMEVKCKPKVGYMKRQPDITNSMRAILVDWLVEVGEEYKLQNETLHLAVN 63
Query: 135 YLDRFLFSFQLQRDKPWMAQLAAVACLSLAAKVEETQVPLLLDLQVEDIKFV----FEAK 190
Y+DRFL S + R K QL A + LA+K EE P +V + ++ + K
Sbjct: 64 YIDRFLSSMSVLRGK---LQLVGTAAMLLASKFEEIYPP-----EVAEFVYITDDTYSKK 115
Query: 191 TIQRMEILVLSTLQWKMNPVTPLSFLDYIARRL---GLKGYLCWEFLKRCDRILLSAISD 247
+ RME LVL L + + T FL L K FL LS I
Sbjct: 116 QVLRMEHLVLKVLAFDLAAPTVNQFLTQYFLHLQPANCKVESLAMFLGE-----LSLIDA 170
Query: 248 SSFMQYLPSVMANATMLHVVQNIESSLGVEYEKQLLNILGTDKDKVEHCSKLIMQLAEQV 307
+++YLPS++A A H+ + + G + + L G + ++ C + Q +
Sbjct: 171 DPYLKYLPSLIAGAA-FHLA--LYTVTGQSWPESLAQQTGYTLESLKPCLVDLHQTYLKA 227
Query: 308 QGQGSQSIKRKF 319
QSI+ K+
Sbjct: 228 PQHAQQSIREKY 239
>pdb|3QHR|B Chain B, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic
pdb|3QHR|D Chain D, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic
pdb|3QHW|B Chain B, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic
pdb|3QHW|D Chain D, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic
Length = 261
Score = 63.9 bits (154), Expect = 2e-10, Method: Compositional matrix adjust.
Identities = 70/252 (27%), Positives = 111/252 (44%), Gaps = 25/252 (9%)
Query: 77 WQDDELSTLLSKEVPNR-LYNILKTNPSLSRA-RSEAVDWMLKVNAHYSFTALTALLAVN 134
+Q+D + L EV + +K P ++ + R+ VDW+++V Y T LAVN
Sbjct: 7 YQEDIHTYLREMEVKCKPKVGYMKRQPDITNSMRAILVDWLVEVGEEYKLQNETLHLAVN 66
Query: 135 YLDRFLFSFQLQRDKPWMAQLAAVACLSLAAKVEETQVPLLLDLQVEDIKFV----FEAK 190
Y+DRFL S + R K QL A + LA+K EE P +V + ++ + K
Sbjct: 67 YIDRFLSSMSVLRGK---LQLVGTAAMLLASKFEEIYPP-----EVAEFVYITDDTYSKK 118
Query: 191 TIQRMEILVLSTLQWKMNPVTPLSFLDYIARRL---GLKGYLCWEFLKRCDRILLSAISD 247
+ RME LVL L + + T FL L K FL LS I
Sbjct: 119 QVLRMEHLVLKVLAFDLAAPTVNQFLTQYFLHLQPANCKVESLAMFLGE-----LSLIDA 173
Query: 248 SSFMQYLPSVMANATMLHVVQNIESSLGVEYEKQLLNILGTDKDKVEHCSKLIMQLAEQV 307
+++YLPS++A A H+ + + G + + L G + ++ C + Q +
Sbjct: 174 DPYLKYLPSLIAGAA-FHLA--LYTVTGQSWPESLAQQTGYTLESLKPCLVDLHQTYLKA 230
Query: 308 QGQGSQSIKRKF 319
QSI+ K+
Sbjct: 231 PQHAQQSIREKY 242
>pdb|4BCQ|D Chain D, Structure Of Cdk2 In Complex With Cyclin A And A
2-amino-4- Heteroaryl-pyrimidine Inhibitor
Length = 262
Score = 61.6 bits (148), Expect = 8e-10, Method: Compositional matrix adjust.
Identities = 56/172 (32%), Positives = 81/172 (47%), Gaps = 21/172 (12%)
Query: 98 LKTNPSLSRA-RSEAVDWMLKVNAHYSFTALTALLAVNYLDRFLFSFQLQRDKPWMAQLA 156
+K P ++ + R+ VDW+++V Y T LAVNY+DRFL S + R K QL
Sbjct: 30 MKKQPDITNSMRAILVDWLVEVGEEYKLQNETLHLAVNYIDRFLSSMSVLRGK---LQLV 86
Query: 157 AVACLSLAAKVEETQVPLLLDLQVEDIKFV----FEAKTIQRMEILVLSTLQWKMNPVTP 212
A + LA+K EE P +V + ++ + K + RME LVL L + + T
Sbjct: 87 GTAAMLLASKFEEIYPP-----EVAEFVYITDDTYTKKQVLRMEHLVLKVLTFDLAAPTV 141
Query: 213 LSFL-DYIARR--LGLKGYLCWEFLKRCDRILLSAISDSSFMQYLPSVMANA 261
FL Y + K FL LS I +++YLPSV+A A
Sbjct: 142 NQFLTQYFLHQQPANCKVESLAMFLGE-----LSLIDADPYLKYLPSVIAAA 188
>pdb|1W98|B Chain B, The Structural Basis Of Cdk2 Activation By Cyclin E
Length = 283
Score = 50.1 bits (118), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 46/169 (27%), Positives = 87/169 (51%), Gaps = 22/169 (13%)
Query: 57 INKTKTIPVPVPMLHEQDLSWQDDE--LSTLLSKEVPN-RLYNILKTNPSLS-RARSEAV 112
I ++ P+PV LSW + E +L+KE R + L+ +P L + R+ +
Sbjct: 2 IAPSRGSPLPV-------LSWANREEVWKIMLNKEKTYLRDQHFLEQHPLLQPKMRAILL 54
Query: 113 DWMLKVNAHYSFTALTALLAVNYLDRFLFSFQLQRDKPWMAQLAAVACLSLAAKVEETQV 172
DW+++V Y T LA ++ DR++ + Q K + QL ++ L +AAK+EE
Sbjct: 55 DWLMEVCEVYKLHRETFYLAQDFFDRYMAT-QENVVKT-LLQLIGISSLFIAAKLEEIYP 112
Query: 173 PLLLDLQVEDIKFVFEAKT----IQRMEILVLSTLQWKMNPVTPLSFLD 217
P ++ +V + I ME++++ L+W+++P+T +S+L+
Sbjct: 113 P-----KLHQFAYVTDGACSGDEILTMELMIMKALKWRLSPLTIVSWLN 156
>pdb|2B9R|A Chain A, Crystal Structure Of Human Cyclin B1
pdb|2B9R|B Chain B, Crystal Structure Of Human Cyclin B1
Length = 269
Score = 44.3 bits (103), Expect = 1e-04, Method: Compositional matrix adjust.
Identities = 30/113 (26%), Positives = 55/113 (48%), Gaps = 12/113 (10%)
Query: 108 RSEAVDWMLKVNAHYSFTALTALLAVNYLDRFLFSFQLQRDKPWMAQLAAVACLSLAAKV 167
R+ +DW+++V + T + V+ +DRF+ + + + M QL V + +A+K
Sbjct: 38 RAILIDWLVQVQMKFRLLQETMYMTVSIIDRFMQNNSVPKK---MLQLVGVTAMFIASKY 94
Query: 168 EETQVPLLLDLQVEDIKFV----FEAKTIQRMEILVLSTLQWKMNPVTPLSFL 216
EE P ++ D FV + I++ME+ +L L + + PL FL
Sbjct: 95 EEMYPP-----EIGDFAFVTDNTYTKHQIRQMEMKILRALNFGLGRPLPLHFL 142
>pdb|2JGZ|B Chain B, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B
Length = 260
Score = 43.9 bits (102), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 30/113 (26%), Positives = 55/113 (48%), Gaps = 12/113 (10%)
Query: 108 RSEAVDWMLKVNAHYSFTALTALLAVNYLDRFLFSFQLQRDKPWMAQLAAVACLSLAAKV 167
R+ +DW+++V + T + V+ +DRF+ + + + M QL V + +A+K
Sbjct: 36 RAILIDWLVQVQMKFRLLQETMYMTVSIIDRFMQNNCVPKK---MLQLVGVTAMFIASKY 92
Query: 168 EETQVPLLLDLQVEDIKFV----FEAKTIQRMEILVLSTLQWKMNPVTPLSFL 216
EE P ++ D FV + I++ME+ +L L + + PL FL
Sbjct: 93 EEMYPP-----EIGDFAFVTDNTYTKHQIRQMEMKILRALNFGLGRPLPLHFL 140
>pdb|2W96|A Chain A, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin
pdb|2W99|A Chain A, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin
pdb|2W9F|A Chain A, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin
Length = 271
Score = 38.5 bits (88), Expect = 0.006, Method: Compositional matrix adjust.
Identities = 33/116 (28%), Positives = 58/116 (50%), Gaps = 4/116 (3%)
Query: 108 RSEAVDWMLKVNAHYSFTALTALLAVNYLDRFLFSFQLQRDKPWMAQLAAVACLSLAAKV 167
R WML+V LA+NYLDRFL L+ K QL C+ +A+K+
Sbjct: 57 RKIVATWMLEVCEEQKCEEEVFPLAMNYLDRFL---SLEPVKKSRLQLLGATCMFVASKM 113
Query: 168 EETQVPLLLDLQVEDIKFVFEAKTIQRMEILVLSTLQWKMNPVTPLSFLDYIARRL 223
+ET +PL + + + +ME+L+++ L+W + +TP F+++ ++
Sbjct: 114 KET-IPLTAEKLCIYTDNSIRPEELLQMELLLVNKLKWNLAAMTPHDFIEHFLSKM 168
>pdb|2W9Z|A Chain A, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin
Length = 257
Score = 38.5 bits (88), Expect = 0.006, Method: Compositional matrix adjust.
Identities = 34/120 (28%), Positives = 59/120 (49%), Gaps = 4/120 (3%)
Query: 104 LSRARSEAVDWMLKVNAHYSFTALTALLAVNYLDRFLFSFQLQRDKPWMAQLAAVACLSL 163
L R WML+V LA+NYLDRFL L+ K QL C+ +
Sbjct: 39 LPSMRKIVATWMLEVCEEQKCEEEVFPLAMNYLDRFL---SLEPVKKSRLQLLGATCMFV 95
Query: 164 AAKVEETQVPLLLDLQVEDIKFVFEAKTIQRMEILVLSTLQWKMNPVTPLSFLDYIARRL 223
A+K++ET +PL + + + +ME+L+++ L+W + +TP F+++ ++
Sbjct: 96 ASKMKET-IPLTAEKLCIYTDNSIRPEELLQMELLLVNKLKWNLAAMTPHDFIEHFLSKM 154
>pdb|1Z52|A Chain A, Proaerolysin Mutant W373l
pdb|1Z52|B Chain B, Proaerolysin Mutant W373l
Length = 470
Score = 30.8 bits (68), Expect = 1.3, Method: Compositional matrix adjust.
Identities = 16/73 (21%), Positives = 33/73 (45%), Gaps = 5/73 (6%)
Query: 141 FSFQLQRDKPWMAQLAAVACLSLAAKVEET-----QVPLLLDLQVEDIKFVFEAKTIQRM 195
S ++ ++ W +Q SL+ V T ++P+ ++L DI + +E K
Sbjct: 255 LSIEIAANQSWASQNGGSTTTSLSQSVRPTVPARSKIPVKIELYKADISYPYEFKADVSY 314
Query: 196 EILVLSTLQWKMN 208
++ + L+W N
Sbjct: 315 DLTLSGFLRWGGN 327
>pdb|1PRE|A Chain A, Proaerolysin
pdb|1PRE|B Chain B, Proaerolysin
Length = 470
Score = 30.8 bits (68), Expect = 1.3, Method: Compositional matrix adjust.
Identities = 16/73 (21%), Positives = 33/73 (45%), Gaps = 5/73 (6%)
Query: 141 FSFQLQRDKPWMAQLAAVACLSLAAKVEET-----QVPLLLDLQVEDIKFVFEAKTIQRM 195
S ++ ++ W +Q SL+ V T ++P+ ++L DI + +E K
Sbjct: 255 LSIEIAANQSWASQNGGSTTTSLSQSVRPTVPARSKIPVKIELYKADISYPYEFKADVSY 314
Query: 196 EILVLSTLQWKMN 208
++ + L+W N
Sbjct: 315 DLTLSGFLRWGGN 327
>pdb|3C0M|A Chain A, Crystal Structure Of The Proaerolysin Mutant Y221g
pdb|3C0M|B Chain B, Crystal Structure Of The Proaerolysin Mutant Y221g
pdb|3C0N|A Chain A, Crystal Structure Of The Proaerolysin Mutant Y221g At 2.2
A
pdb|3C0N|B Chain B, Crystal Structure Of The Proaerolysin Mutant Y221g At 2.2
A
pdb|3C0O|A Chain A, Crystal Structure Of The Proaerolysin Mutant Y221g
Complexed With Mannose-6-Phosphate
pdb|3C0O|B Chain B, Crystal Structure Of The Proaerolysin Mutant Y221g
Complexed With Mannose-6-Phosphate
Length = 470
Score = 30.8 bits (68), Expect = 1.3, Method: Compositional matrix adjust.
Identities = 16/73 (21%), Positives = 33/73 (45%), Gaps = 5/73 (6%)
Query: 141 FSFQLQRDKPWMAQLAAVACLSLAAKVEET-----QVPLLLDLQVEDIKFVFEAKTIQRM 195
S ++ ++ W +Q SL+ V T ++P+ ++L DI + +E K
Sbjct: 255 LSIEIAANQSWASQNGGSTTTSLSQSVRPTVPARSKIPVKIELYKADISYPYEFKADVSY 314
Query: 196 EILVLSTLQWKMN 208
++ + L+W N
Sbjct: 315 DLTLSGFLRWGGN 327
>pdb|3G4O|A Chain A, Crystal Structure Of The Activated Aerolysin Mutant H132n
pdb|3G4O|B Chain B, Crystal Structure Of The Activated Aerolysin Mutant H132n
Length = 470
Score = 30.8 bits (68), Expect = 1.3, Method: Compositional matrix adjust.
Identities = 16/73 (21%), Positives = 33/73 (45%), Gaps = 5/73 (6%)
Query: 141 FSFQLQRDKPWMAQLAAVACLSLAAKVEET-----QVPLLLDLQVEDIKFVFEAKTIQRM 195
S ++ ++ W +Q SL+ V T ++P+ ++L DI + +E K
Sbjct: 255 LSIEIAANQSWASQNGGSTTTSLSQSVRPTVPARSKIPVKIELYKADISYPYEFKADVSY 314
Query: 196 EILVLSTLQWKMN 208
++ + L+W N
Sbjct: 315 DLTLSGFLRWGGN 327
>pdb|3G4N|A Chain A, Crystal Structure Of The Activated Aerolysin Mutant H132d
pdb|3G4N|B Chain B, Crystal Structure Of The Activated Aerolysin Mutant H132d
Length = 470
Score = 30.8 bits (68), Expect = 1.4, Method: Compositional matrix adjust.
Identities = 16/73 (21%), Positives = 33/73 (45%), Gaps = 5/73 (6%)
Query: 141 FSFQLQRDKPWMAQLAAVACLSLAAKVEET-----QVPLLLDLQVEDIKFVFEAKTIQRM 195
S ++ ++ W +Q SL+ V T ++P+ ++L DI + +E K
Sbjct: 255 LSIEIAANQSWASQNGGSTTTSLSQSVRPTVPARSKIPVKIELYKADISYPYEFKADVSY 314
Query: 196 EILVLSTLQWKMN 208
++ + L+W N
Sbjct: 315 DLTLSGFLRWGGN 327
>pdb|2I53|A Chain A, Crystal Structure Of Cyclin K
Length = 258
Score = 30.4 bits (67), Expect = 1.9, Method: Compositional matrix adjust.
Identities = 41/177 (23%), Positives = 70/177 (39%), Gaps = 30/177 (16%)
Query: 105 SRARSEAVDWMLKVNAHYSFTALTALLAVNYLDRFLFSFQLQRDKPWMAQLAAVACLSLA 164
+R R E ++ V T + Y RF + K + + CL LA
Sbjct: 38 ARYRREGARFIFDVGTRLGLHYDTLATGIIYFHRF---YMFHSFKQFPRYVTGACCLFLA 94
Query: 165 AKVEE----------TQVPLLLDLQVEDIKFVFEAK-TIQRMEILVLSTLQWKMNPVTPL 213
KVEE T LL D+Q +F + K + +E ++L T+++ + P
Sbjct: 95 GKVEETPKKCKDIIKTARSLLNDVQFG--QFGDDPKEEVMVLERILLQTIKFDLQVEHPY 152
Query: 214 SFLDYIARRL-GLKG------YLCWEFLKRCDRILLSAISDSSFMQYLPSVMANATM 263
FL A++L G K + W F+ ++ + +Q+ P ++A A M
Sbjct: 153 QFLLKYAKQLKGDKNKIQKLVQMAWTFVN-------DSLCTTLSLQWEPEIIAVAVM 202
Database: pdbaa
Posted date: Mar 3, 2013 10:34 PM
Number of letters in database: 14,973,337
Number of sequences in database: 62,578
Lambda K H
0.321 0.134 0.398
Lambda K H
0.267 0.0410 0.140
Matrix: BLOSUM62
Gap Penalties: Existence: 11, Extension: 1
Number of Hits to DB: 9,628,341
Number of Sequences: 62578
Number of extensions: 332674
Number of successful extensions: 842
Number of sequences better than 100.0: 33
Number of HSP's better than 100.0 without gapping: 21
Number of HSP's successfully gapped in prelim test: 12
Number of HSP's that attempted gapping in prelim test: 793
Number of HSP's gapped (non-prelim): 33
length of query: 394
length of database: 14,973,337
effective HSP length: 101
effective length of query: 293
effective length of database: 8,652,959
effective search space: 2535316987
effective search space used: 2535316987
T: 11
A: 40
X1: 16 ( 7.4 bits)
X2: 38 (14.6 bits)
X3: 64 (24.7 bits)
S1: 41 (21.9 bits)
S2: 52 (24.6 bits)